Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
3.72 EUR | +0.27% | -0.11% | -21.19% |
Apr. 11 | Valneva: Deep Track Biotechnology Master holds less than 5% of the capital | CF |
Mar. 26 | Valneva Kicks Off Early-stage Trial for Zika Vaccine Candidate | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-21.19% | 548M | |
+2.33% | 42.11B | |
+49.22% | 40.08B | |
+8.50% | 40B | |
-11.32% | 26.87B | |
+7.08% | 24.58B | |
-21.95% | 18.44B | |
+2.05% | 11.94B | |
+29.16% | 11.66B | |
+8.15% | 11.01B |
- Stock Market
- Equities
- VLA Stock
- News Valneva
- Valneva To Complete US FDA Application For Chikungunya Vaccine Candidate By 2022-end